Free Newsletter
Insurers schmooze docs on generics
All the doctors had to do was show up, enjoy a free dinner at an elegant Rochester, N.Y., steakhouse, and pocket $100 on the way out. Sound like a pharma promo? Nope, health insurers had invited them to hear a pitch about the benefits of prescribing generics instead of their pricier, name-brand competitors. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: